Full Text View
Tabular View
No Study Results Posted
Related Studies
Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer
This study has been completed.
Study NCT00060242   Information provided by National Cancer Institute (NCI)
First Received: May 6, 2003   Last Updated: March 26, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Head and Neck Cancer
Additional conditions recognized in this trial
Head and Neck Neoplasms
Thyroid Neoplasms
More general conditions related to this trial
Endocrine Gland Neoplasms
Endocrine System Diseases
Neoplasms
Neoplasms by Site
Thyroid Diseases
Interventions listed in this trial
combretastatin A4 phosphate
Additional drug interventions recognized in this trial
Combretastatin
Combretastatin A-4
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Case Comprehensive Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services